Plain-English translation of NCT07367698 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach to breast surgery that uses a medical-grade material called polycaprolactone (PCL) scaffold combined with your own fat tissue. The PCL scaffold is designed to support soft tissue while your body gradually absorbs it over time, and researchers want to see if this method is safe and effective for people having breast implants removed and replaced, or for people having breast augmentation for the first time.
Some people experience complications after breast implant surgery or want to explore alternatives to traditional implants. This trial exists to see if the new treatment could offer a safer, more natural option that works with your body's own tissue rather than relying solely on implants.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have the surgical procedure to remove your old implant (if applicable) and receive the new PCL scaffold with fat grafting. After surgery, you'll attend follow-up visits at 1 week, 3 months, 6 months, and then yearly for up to 5 years to let doctors check how you're healing and answer questionnaires about your experience. The study involves imaging scans (like MRI) and regular clinical assessments to track the safety and effectiveness of the treatment.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
Australia